DGX

Quest Diagnostics
D

DGX

Arincen63/100B

Quest Diagnostics shares outstanding 1996–2026

Quest Diagnostics had 110,373,360 shares outstanding on 8 November 2026. Quest Diagnostics had 112.00M diluted shares on average over the last twelve months, down 0.9% on the twelve months before. In fiscal year 2025 the average was 113.00M.

Last updated 7 Nov 2026 · Next report 9 Feb 2027

Shares outstanding

Change on the year

Fiscal yearPeriod endingShares outstandingChange on the yearBasic shares
TTM30 Sept 2026112.00M-0.88%110.25M
FY202531 Dec 2025113.00M0.00%111.00M
FY202431 Dec 2024113.00M0.00%111.00M
FY202331 Dec 2023113.00M-4.24%112.00M
FY202231 Dec 2022118.00M-7.81%116.00M
FY202131 Dec 2021128.00M-5.88%125.00M
FY202031 Dec 2020136.00M0.00%134.00M
FY201931 Dec 2019136.00M-2.16%134.00M
FY201831 Dec 2018139.00M-0.71%136.00M
FY201731 Dec 2017140.00M-1.41%137.00M
FY201631 Dec 2016142.00M-2.07%140.00M
FY201531 Dec 2015145.00M0.00%144.00M
FY201431 Dec 2014145.00M-5.23%145.00M
FY201331 Dec 2013153.00M-4.43%152.00M
FY201231 Dec 2012160.10M-0.06%158.60M
FY201131 Dec 2011160.20M-9.64%158.70M
FY201031 Dec 2010177.30M-5.59%175.70M
FY200931 Dec 2009187.80M-4.18%185.90M
FY200831 Dec 2008196.00M+0.38%194.30M
FY200731 Dec 2007195.26M-2.14%193.24M
FY200631 Dec 2006199.54M-2.91%196.99M
FY200531 Dec 2005205.53M-3.25%201.83M
FY200431 Dec 2004212.42M-1.75%203.75M
FY200331 Dec 2003216.20M+8.38%206.97M
FY200231 Dec 2002199.48M+2.01%192.91M
FY200131 Dec 2001195.55M+3.47%186.56M
FY200031 Dec 2000188.99M+38.96%179.04M
FY199931 Dec 1999136.00M+12.49%136.00M
FY199831 Dec 1998120.90M+4.09%119.56M
FY199731 Dec 1997116.15M-1.11%115.84M
FY199631 Dec 1996117.45M—117.45M

Figures in USD. Shares and EPS are adjusted for stock splits. Quarterly growth is on the same quarter a year before; TTM is the last four quarters.

See also:Revenue,Net income,EPS,Operating income,Cash on hand,Total debt,Free cash flow,Stock buybacks,Income statement

Common questions about Quest Diagnostics's shares

Source: Financial Modeling Prep

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Never invest money you cannot afford to lose, and carefully assess the suitability of complex products such as CFDs and derivatives in light of your financial situation. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

© 2026 - Arincen L.L.C-FZ - License No. 2420098.01. All Rights Reserved.